A randomized, double blind, placebo controlled, cross over, two group, two period study to evaluate the efficacy of SabeetÂ® in cardio vascular and exercise performance in 20 adult male healthy volunteers.

Sami labs Limited0 个研究点目标入组 20 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1 Male healthy adult subjects ranging in age from 18 to 55 years (both inclusive) normotensive, physically active but not exercise trained.
•2 Willingness to follow the protocol requirements as evidenced by written, informed consent.
•3 Agree not to use any medication (prescription and over the counter), including vitamins and
•minerals, during or before the course of this study.
•4 Subjects whose blood chemistries are within a normal range or not considered clinically
•significant if outside the normal range.
•5 Non-smokers and non-alcoholics.
•6 Willing to come for all follow-up visits.

•1 Any clinically significant medical history, medical finding or an ongoing medical or psychiatric condition exists which in the opinion of the Investigator could jeopardize the safety of the subject, impact validity of the study results or interfere with the completion of study according to the protocol.
•2 Significant abnormal findings as determined by baseline history, physical examination, vital signs (blood pressure, pulse rate, respiration rate, temperature) haematology, serum chemistry.
•3 History of hypersensitivity reactions.
•4 Participation in a clinical study during the preceding 90 days.
•5 Any contraindication to blood sampling.
•6 Blood or blood products donated in past 30 days prior to study supplement administration.

发起方

Sami labs Limited